CollPlant Biotechnologies Ltd (CLGN) income statement
CLGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as OPHI
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 9/30
$3.96+0.06 (+1.54%)
Close on Nov 11, 2026Market cap $5.72MP/E –Yield –
CollPlant Biotechnologies Ltd income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY2025
- Gross margin
- 64.8%
- Operating margin
- -484.3%
- Net margin
- -484.6%
- Return on equity, FY2025
- -117.6%
Financial strength
- Current ratio
- 1.57
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 102.9%
Valuation
- P/E ratio
- –
- Price to sales
- 2.41
- Price to book
- 1.94
- Dividend yield
- –
See a number that looks wrong?